Pfizer chasing AstraZeneca in potential $100 billion deal

LONDON (Reuters) – U.S. drugmaker Pfizer Inc is working on its next move in a potential $100 billion bid battle for Britain’s AstraZeneca Plc after having two bids rejected, as deal-making grips the healthcare industry.

Link to article:


Leave a Reply

Your email address will not be published. Required fields are marked *